If you buy legal medical cannabis in Los Angeles today, you’re lucky to find a reliable THC reading for most products on the menu. You’re even less likely to see information about levels of cannabinoids such as CBD, CBG, or CBN. Nor would you see much about terpenes, despite their increasing importance to patients and connoisseurs alike.
Remember, we’re talking legal, medical cannabis—adult-use stores won’t be licensed until 2018. Yet what’s in the cannabis is still largely a mystery. When the only guidance is the sniff of a jar and the recommendation of a budtender, is it any surprise so many people still think all pot is created equal?
Get ready for that to change. Testing requirements under California’s newly passed Prop. 64 will, in theory, bring an unprecedented level of transparency.
With more questions come more answers, and with more answers comes a better understanding of the plant.
As the law is written, all legal cannabis products must be sampled by an independent laboratory and tested for cannabinoids THC, THCA, CBD, CBDA, CBG, CBN, as well as the “terpenes described in the most current version of the cannabis inflorescence monograph published by the American Herbal Pharmacopoeia.” Which is available here if you want to check. (Here’s a preview.)
To most Americans, all those cannabinoids are just a lot of letters. Terpenes are still exotic unpronounceables in most circles. That’s precisely the point. Testing for cannabinoid and terpene levels may spark greater consumer interest in those compounds. With more questions come more answers, and with more answers comes a better understanding of the plant.
Story Source: The above story is based on materials provided by LEAFLY
No comments:
Post a Comment